Analyst Ranking
Bottom 16%
#3738 out of 4414 analysts
Average Return
Win Rate
41%26 out of 64
Risk vs Reward

David Lebovitz's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Clementia Pharmaceuticals IncCMTA
2018-08-12 -
Strong Buy
Avexis IncAVXS
2017-08-02 -
Strong Buy
Avexis IncAVXS
2017-11-12 -
Strong Buy
Epizyme IncEPZM
2021-08-09 -
Strong Sell
Avexis IncAVXS
2018-03-05 -
Strong Buy

David Lebovitz's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Bridgebio Pharma IncBBIO
1Strong Buy$42.00+45.63%Initiates Coverage On
22 days ago
Ptc Therapeutics IncPTCT
6Strong Sell$17.00-22.34%Downgrades
a month ago
Alnylam Pharmaceuticals IncALNY
19Strong Buy$233.00+44.40%Maintains
2 months ago
Ionis Pharmaceuticals IncIONS
9Strong Buy$60.00+24.12%Upgrades
4 months ago
Incyte CorpINCY
1Strong Buy$82.00+55.60%Initiates Coverage On
4 months ago
Biomarin Pharmaceutical IncBMRN
5 months ago
Schrodinger IncSDGR
4Strong Buy$50.00+59.95%Maintains
7 months ago
Ascendis Pharma AASND
8Strong Buy$146.00+61.11%Maintains
8 months ago
Pliant Therapeutics IncPLRX
3Strong Buy$50.00+253.11%Maintains
9 months ago
Intellia Therapeutics IncNTLA
10 months ago
Mirum Pharmaceuticals IncMIRM
2Strong Buy$34.00N/AMaintains
a year ago
Immuneering CorpIMRX
a year ago
Blueprint Medicines CorpBPMC
5Strong Sell$41.00N/ADowngrades
a year ago
Arcutis Biotherapeutics IncARQT
5Strong Buy$36.00N/AMaintains
2 years ago
Syndax Pharmaceuticals IncSNDX
2 years ago
Karyopharm Therapeutics IncKPTI
2Strong Buy$27.00N/AMaintains
2 years ago
Ironwood Pharmaceuticals IncIRWD
2 years ago
Avrobio IncAVRO
3Strong Buy$25.00N/AMaintains
2 years ago
Epizyme IncEPZM
2Strong Sell$5.00N/ADowngrades
2 years ago
Rhythm Pharmaceuticals IncRYTM
2Strong Buy$57.00N/AMaintains
3 years ago
Macrogenics IncMGNX
1Strong Sell$15.00N/AMaintains
3 years ago
Gw Pharmaceuticals PLCGWPH
3 years ago
Nabriva Therapeutics PLCNBRVF
3 years ago
Zealand Pharma AZEAL
1Strong Buy$37.00N/AMaintains
4 years ago
Clementia Pharmaceuticals IncCMTA
2Strong Buy$26.00N/AMaintains
5 years ago
Avexis IncAVXS
3Strong Buy$129.00N/AMaintains
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.